CANTARINI LUCA

Office hours

  • Wednesday from 08:00 to 09:00
    Place: Direzione di Reumatologia
    Note: previa conferma disponibilità ed appuntamento scrivendo a cantarini@unisi.it

Teaching activities

Completion accademic year: 2024/2025

Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2021/2022

Completion accademic year: 2023/2024

Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2020/2021

Completion accademic year: 2022/2023

Research

Ultime pubblicazioni:

  • Talarico, R., Italiano, N., Emmi, G., Piga, M., Cantarini, L., Mattioli, I., et al. (2024). Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet’s syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial. ANNALS OF THE RHEUMATIC DISEASES [10.1136/ard-2024-226113]. - view more
  • Grazzini, S., Conticini, E., Giorli, A., Gentileschi, S., Cantarini, L., Frediani, B. (2024). Clinical spectrum of small-vessel vasculitis related to cocaine consumption: data from an Italian cohort. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY [10.55563/clinexprheumatol/z41j3b]. - view more
  • Fonollosa, A., Carreno, E., Vitale, A., Jindal, A.K., Ramanan, A.V., Pelegrin, L., et al. (2024). Update on ocular manifestations of the main monogenic and polygenic autoinflammatory diseases. FRONTIERS IN OPHTHALMOLOGY, 4 [10.3389/fopht.2024.1337329]. - view more
  • D'Ignazio, E., Trovato, E., Cantarini, L., Calabrese, L., Frediani, B., Gentileschi, S. (2024). Clinical response to brodalumab in a patient affected by refractory SAPHO syndrome. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY [10.55563/clinexprheumatol/qhq2o0]. - view more
  • Vitale, A., Caggiano, V., Martín-Nares, E., Di Meglio, N., Sica, C., Hinojosa-Azaola, A., et al. (2024). Dry eye disease and spondyloarthritis: expanding the spectrum of systemic inflammatory disorders associated with ocular surface disease. Data from the international AIDA Network Spondyloarthritis Registry. FRONTIERS IN MEDICINE, 11 [10.3389/fmed.2024.1422307]. - view more